Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04866251
Other study ID # Gag Reflex - 1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 10, 2016
Est. completion date February 1, 2024

Study information

Verified date November 2023
Source University of Giessen
Contact Samra Hamzic, M.A.
Phone +49 641 985 59233
Email samra.hamzic@neuro.med.uni-giessen.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to assess the prevalence of gag reflex in healthy young and healthy older subjects as well as in acute stroke patients, in patients with Parkinsons´s Disease, Myasthenia gravis, Multiple Sclerosis and in geriatric patients.


Description:

In the clinical swallowing examination in acute stroke setting it is assumed that the absence of gag reflex is a predictor of aspiration risk. According to Daniels et al. (1997) aspiration can be predicted with 96% sensitivity in case of absent or abnormal gag reflex. In clinical experience of investigators testing of gag reflex highly depends on patients´compliance and individual anatomical features such as Mallampati score. Furthermore, even if gag reflex is absent, swallowing does not have to be impaired. The presence of gag reflex in healthy cohorts and dysphagic patients has been examined in a few studies. Davies et al. (1995) have shown that in 37% of healthy volunteers gag reflex was absent. Ramsey et al. (2005) have shown that approx. 89% of the patients without gag reflex had dysphagia and 31% without dysphagia had a gag reflex. In both studies it was not stated to what extent the gag reflex could be examined in case of a high Mallampati score. The present study aims at assessing the prevalence of gag reflex in healthy and neurological cohorts. The study protocol foresees testing of gag reflex in different oral areas (tongue, velum, pharyngeal wall) and evaluating present reactions. The Mallampati score is assessed in order to evaluate the feasibility of gag reflex test in case of higher Mallampati scores. All patients are tested once by one examiner.


Recruitment information / eligibility

Status Recruiting
Enrollment 700
Est. completion date February 1, 2024
Est. primary completion date February 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - informed consent Exclusion Criteria: 1. Healthy participants: Neurological diseases Pre-diagnosed dysphagia Percutaneous endoscopic gastrostomy (PEG) tube Head and neck tumours Chemo- and/or radiotherapy in the head and neck area Reflux disease Chronic obstructive pulmonary disease (COPD) Previous surgeries on the cervical spine or thyroid gland Vocal cord paresis 2. Geriatric patients Neurologic diseases 3. Stroke patients Head and neck tumours Chemo- and/or radiotherapy in the head and neck area Reflux disease COPD Previous surgeries on the cervical spine or thyroid gland Vocal cord paresis 4. Neurologic patients without stroke Head and neck tumours (except of intracranial tumors= Chemo- and/or radiotherapy in the head and neck area Reflux disease COPD Previous surgeries on the cervical spine or thyroid gland Vocal cord paresis

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Gag reflex test; assessment of Mallampati Score
Testing of gag reflex Assessment of Mallampati Score

Locations

Country Name City State
Germany University Hospital Giessen and Marburg Gießen Hessen

Sponsors (1)

Lead Sponsor Collaborator
University of Giessen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of gag reflex Prevalence of gag reflex Baseline
See also
  Status Clinical Trial Phase
Terminated NCT03128086 - Weaning From Mechanical Ventilation in Neurological Patients N/A
Recruiting NCT04581577 - Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders
Active, not recruiting NCT05742087 - Neuropathy and Anti-GFAP Antibodies
Recruiting NCT05645003 - Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients N/A
Withdrawn NCT04377425 - COVID-19 Prevalence and Cognitive Deficits in Neurological Patients
Withdrawn NCT01898975 - A Gray Zone Approach to Stroke Volume Variation Derived From NICOM N/A
Active, not recruiting NCT03480581 - Impact of Reverse vs. Forward ICARE Training Interventions N/A
Completed NCT04061616 - Transcultural Validation of the Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) in French: The PASIPD-Fr N/A
Recruiting NCT04706481 - Archival of Human Biological Samples in CU-Med Biobank
Completed NCT05169788 - Rehabilitation Through the Italian Version of the Teen Online Problem-Solving (TOPS) Program N/A
Completed NCT03619642 - Reliability, Validity and Clinical Utility of a Robotic Assessment for Proprioception N/A
Recruiting NCT05526508 - Rebound Exercise in Neurological Disorders N/A
Recruiting NCT05086380 - Modulation of Sense of Agency With Non-invasive Brain Stimulation and Mindfulness-based Stress Reduction Therapy N/A
Not yet recruiting NCT05796037 - An Observational Study of Patients Living With Chronic Neurological Diseases
Recruiting NCT03777267 - Cereset Research Exploratory Study N/A
Completed NCT05097066 - Patterns and Outcomes of Neurosurgery in England Over a Five-year Period